Pharma stock picks: Is tariff threat over? In Trump era, you have to read between the lines: 8 pharma stocks with upside potential of over 35%

Published:



For the next four years, learn to look for what is actually happening on the ground rather than what is being said by US President Trump. Because, the divergence between what he says and what he does cannot be predicted. Now, for the last many months, fears of tariffs being imposed on pharmaceutical products have dominated the narrative on the street. The reality that has emerged is Trump asking some US companies to reduce the prices of drugs



Source link

Related articles

spot_img

Recent articles